Medical Education Library

Emerging Treatment Options for Postinflammatory Hyperpigmentation


 

A supplement to Skin & Allergy News. This supplement is jointly sponsored by Skin & Allergy News and the Elsevier Office of Continuing Medical Education and supported by Barrier Therapeutics. The supplement is based on a faculty interview.



To view the supplement, click the image above. To take the CME Posttest, download and print out the CME Posttest PDF file, and follow the test instructions.

FACULTY

Susan Taylor, MD
Director, The Skin of Color Center
St. Luke's-Roosevelt Hospital
Columbia University
New York, N.Y.

TARGET AUDIENCE

This activity has been designed to meet the educational needs of Dermatologists and other clinicians.

EDUCATIONAL NEEDS

Disorders of skin pigmentation account for a substantial proportion of many dermatologists' practices. Abnormalities characterized by hyperpigmentation are especially prominent among African-Americans and other darker-skinned individuals. Postinflammatory hyperpigmentation (PIH), an acquired increase in pigmentation secondary to an inflammatory process, is one of the common pigmentation disorders among people of color. PIH poses a therapeutic challenge to the clinician, and many patients find the condition more troubling than its inflammatory precursor. PIH can have a devastating psychological impact and substantially mar an individual's self-esteem.

LEARNING OBJECTIVES

Upon completion of this educational activity, participants should be able to:

• Understand the basic pathophysiology of PIH

• State the principal types of conditions that result in PIH

• Appreciate the impact of PIH and its effects on people of color

• Appreciate the impact of PIH and its effects on people of color

ACCREDITATION STATEMENT

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Elsevier Office of ContinuingMedical Education (EOCME) and Skin & Allergy News. The EOCME is accredited by the ACCME to provide continuing medical education (CME) for physicians.

CREDIT DESIGNATION

The EOCME designates this educational activity for a maximum of 0.5 AMA PRA Category 1 Credits. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Term of Approval: October 2007 - October 31, 2008.


*Full faculty disclosures available online.

Next Article: